Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BIAF save search
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
Published: 2023-01-24 (Crawled : 15:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 18.87%
H: 0.0%
C: 0.0%
research respiratory trial results publication
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
| Email alert
Add to watchlist
award patent for cancer
Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)
Published: 2022-12-19 (Crawled : 17:00) - prnewswire.com
BIAF | $2.26 -3.0% 22K
|
|
| O: -1.99%
H: 5.58%
C: -4.57%
research report
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Published: 2022-12-01 (Crawled : 14:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 1.26%
H: 2.05%
C: 1.32%
research meeting cancer
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 3.46%
H: 0.0%
C: 0.0%
financial update results
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 1.05%
H: 14.52%
C: 6.22%
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
Published: 2022-11-08 (Crawled : 13:20) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 2.14%
H: 5.22%
C: -0.96%
report financial results
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 2.94%
H: 2.68%
C: -0.36%
lung conference flow results
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
Published: 2022-09-28 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.26 -3.0% 22K
|
|
| O: 61.43%
H: 17.5%
C: -18.89%
offering
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
Published: 2022-09-14 (Crawled : 13:00) - biospace.com/
BIAF | $2.26 -3.0% 22K
|
|
| O: 30.14%
H: 19.3%
C: -14.74%
lung for health flow one results
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
Published: 2022-09-06 (Crawled : 16:00) - feed.businesswire.com
BIAF | $2.26 -3.0% 22K
|
|
| O: -10.07%
H: 3.94%
C: -14.98%
offering
WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit
Published: 2022-09-01 (Crawled : 17:00) - prnewswire.com
BIAF | $2.26 -3.0% 22K
|
| Email alert
Add to watchlist
bioAffinity Technologies Announces Pricing of IPO
Published: 2022-09-01 (Crawled : 12:20) - feed.businesswire.com
BIAF | $2.26 -3.0% 22K
|
| Email alert
Add to watchlist
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
DGLY | News | $5.2 1644.97% 110K
|
Electronic Technology
CELZ | $1.25 141.64% 110M
|
BJDX | $0.619 32.66% 2.1M
|
KPRX | News | $6.0 31.87% 6M
|
Manufacturing
GFAI | $0.45 31.77% 47M
|
PRFX | $0.625 25.0% 12M
|
Health Technology
MSGM P 1 d | $16.28 23.52% 4.7M
|
BBLG | $0.3799 20.76% 670K
|
n/a
THCH | $5.03 19.76% 410K
|
n/a
NEWR A | $77.26 19.63% 2.3M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.